Lysosomal membrane protein LAPTM5: implications for nervous system pathology

Lysosomal dysfunction is implicated in the pathogenesis of various neurological disorders. LAPTM5, a lysosomal membrane protein, participates in the regulation of lysosomal function, autophagy, and immune responses. Emerging evidence suggests that LAPTM5 exerts context-dependent effects across different neurological diseases. LAPTM5 protects against cerebral ischemia/reperfusion injury but contributes to secondary brain injury following intracerebral hemorrhage. It is also associated with neuroinflammatory processes in Alzheimer's disease and neuropathic pain, although causal evidence remains limited in certain contexts. In neuroblastoma, LAPTM5 promotes lysosome-mediated tumor cell death, whereas its functions in glioma appear to depend on tumor subtype and molecular context. This review summarizes the molecular characteristics and regulatory mechanisms of LAPTM5, examines its diverse roles in neurological and nervous system-related disorders, and discusses its potential as a biomarker and therapeutic target. We also highlight current research limitations and future directions, emphasizing the need for multi-omics approaches and cell-type-specific functional studies to clarify the mechanisms of LAPTM5 and support its clinical translation.

Authors

Institutions

Publication Details

Journal
Cell Biology and Toxicology
Published
2026-11-20
DOI
https://doi.org/10.1007/s10565-026-10340-7
Primary Topic
Autophagy in Disease and Therapy
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Lysosomal membrane protein LAPTM5: implications for nervous system pathology

Dongqiong Xiao, Lingli Pan, Qian Zhang
2 links
Cell Biology and Toxicology
Autophagy in Disease and Therapy
article

Lysosomal membrane protein LAPTM5: implications for nervous system pathology

Dongqiong Xiao, Lingli Pan, Qian Zhang
article en

Abstract

Lysosomal dysfunction is implicated in the pathogenesis of various neurological disorders. LAPTM5, a lysosomal membrane protein, participates in the regulation of lysosomal function, autophagy, and immune responses. Emerging evidence suggests that LAPTM5 exerts context-dependent effects across different neurological diseases. LAPTM5 protects against cerebral ischemia/reperfusion injury but contributes to secondary brain injury following intracerebral hemorrhage. It is also associated with neuroinflammatory processes in Alzheimer's disease and neuropathic pain, although causal evidence remains limited in certain contexts. In neuroblastoma, LAPTM5 promotes lysosome-mediated tumor cell death, whereas its functions in glioma appear to depend on tumor subtype and molecular context. This review summarizes the molecular characteristics and regulatory mechanisms of LAPTM5, examines its diverse roles in neurological and nervous system-related disorders, and discusses its potential as a biomarker and therapeutic target. We also highlight current research limitations and future directions, emphasizing the need for multi-omics approaches and cell-type-specific functional studies to clarify the mechanisms of LAPTM5 and support its clinical translation.

Cell Biology and Toxicology
Sichuan University (CN), West China Second University Hospital of Sichuan University (CN), Chengdu Women's and Children's Central Hospital (CN)
National Natural Science Foundation of China
Good health and well-being
Autophagy in Disease and Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon